TY - STD TI - Arthritis in Canada: an ongoing challenge. 2003 ID - ref1 ER - TY - JOUR AU - Scott, D. L. AU - Symmons, D. P. AU - Coulton, B. L. AU - Popert, A. J. PY - 1987 DA - 1987// TI - Long-term outcome of treating rheumatoid arthritis: results after 20 years JO - Lancet VL - 1 UR - https://doi.org/10.1016/S0140-6736(87)91672-2 DO - 10.1016/S0140-6736(87)91672-2 ID - Scott1987 ER - TY - JOUR AU - Pincus, T. AU - Callahan, L. F. PY - 1986 DA - 1986// TI - Taking mortality in rheumatoid arthritis seriously--predictive markers, socioeconomic status and comorbidity JO - J Rheumatol VL - 13 ID - Pincus1986 ER - TY - JOUR AU - Choy, E. H. AU - Panayi, G. S. PY - 2001 DA - 2001// TI - Cytokine pathways and joint inflammation in rheumatoid arthritis JO - N Engl J Med VL - 344 UR - https://doi.org/10.1056/NEJM200103223441207 DO - 10.1056/NEJM200103223441207 ID - Choy2001 ER - TY - JOUR AU - Saxne, T. AU - Palladino, M. A. AU - Heinegard, D. AU - Talal, N. AU - Wollheim, F. A. PY - 1988 DA - 1988// TI - Detection of tumor necrosis factor alpha but not tumor necrosis factor beta in rheumatoid arthritis synovial fluid and serum JO - Arthritis Rheum VL - 31 UR - https://doi.org/10.1002/art.1780310816 DO - 10.1002/art.1780310816 ID - Saxne1988 ER - TY - JOUR AU - Di Giovine, F. S. AU - Nuki, G. AU - Duff, G. W. PY - 1988 DA - 1988// TI - Tumour necrosis factor in synovial exudates JO - Ann Rheum Dis VL - 47 UR - https://doi.org/10.1136/ard.47.9.768 DO - 10.1136/ard.47.9.768 ID - Di Giovine1988 ER - TY - JOUR AU - Firestein, G. S. AU - Alvaro-Gracia, J. M. AU - Maki, R. PY - 1990 DA - 1990// TI - Quantitative analysis of cytokine gene expression in rheumatoid arthritis JO - J Immunol VL - 144 ID - Firestein1990 ER - TY - JOUR AU - Salfeld, J. AU - Kaymakcalan, Z. AU - Tracey, D. AU - Roberts, A. AU - Kamen, R. PY - 1998 DA - 1998// TI - Generation of fully human anti-TNF antibody D2E7 JO - ARTHRITIS RHEUM VL - 41 ID - Salfeld1998 ER - TY - JOUR AU - Barrera, P. AU - Joosten, L. A. AU - den Broeder, A. A. AU - van de Putte, L. B. AU - van Riel, P. L. AU - van den Berg, W. B. PY - 2001 DA - 2001// TI - Effects of treatment with a fully human anti-tumour necrosis factor alpha monoclonal antibody on the local and systemic homeostasis of interleukin 1 and TNFalpha in patients with rheumatoid arthritis JO - Ann Rheum Dis VL - 60 UR - https://doi.org/10.1136/ard.60.7.660 DO - 10.1136/ard.60.7.660 ID - Barrera2001 ER - TY - JOUR AU - Furst, D. E. AU - Schiff, M. H. AU - Fleischmann, R. M. AU - Strand, V. AU - Birbara, C. A. AU - Compagnone, D. AU - Fischkoff, S. A. AU - Chartash, E. K. PY - 2003 DA - 2003// TI - Adalimumab, a fully human anti tumor necrosis factor-alpha monoclonal antibody, and concomitant standard antirheumatic therapy for the treatment of rheumatoid arthritis: results of STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis) JO - J Rheumatol VL - 30 ID - Furst2003 ER - TY - JOUR AU - Weinblatt, M. E. AU - Keystone, E. C. AU - Furst, D. E. AU - Moreland, L. W. AU - Weisman, M. H. AU - Birbara, C. A. AU - Teoh, L. A. AU - Fischkoff, S. A. AU - Chartash, E. K. PY - 2003 DA - 2003// TI - Adalimumab, a fully human anti-tumor necrosis factor alpha monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: the ARMADA trial JO - Arthritis Rheum VL - 48 UR - https://doi.org/10.1002/art.10697 DO - 10.1002/art.10697 ID - Weinblatt2003 ER - TY - JOUR AU - Keystone, E. C. AU - Kavanaugh, A. F. AU - Sharp, J. T. AU - Tannenbaum, H. AU - Hua, Y. AU - Teoh, L. S. AU - Fischkoff, S. A. AU - Chartash, E. K. PY - 2004 DA - 2004// TI - Radiographic, clinical, and functional outcomes of treatment with adalimumab (a human anti-tumor necrosis factor monoclonal antibody) in patients with active rheumatoid arthritis receiving concomitant methotrexate therapy: a randomized, placebo-controlled, 52-week trial JO - Arthritis Rheum VL - 50 UR - https://doi.org/10.1002/art.20217 DO - 10.1002/art.20217 ID - Keystone2004 ER - TY - JOUR AU - van de Putte, L. B. AU - Atkins, C. AU - Malaise, M. AU - Sany, J. AU - Russell, A. S. AU - van Riel, P. L. AU - Settas, L. AU - Bijlsma, J. W. AU - Todesco, S. AU - Dougados, M. PY - 2004 DA - 2004// TI - Efficacy and safety of adalimumab as monotherapy in patients with rheumatoid arthritis for whom previous disease modifying antirheumatic drug treatment has failed JO - Ann Rheum Dis VL - 63 UR - https://doi.org/10.1136/ard.2003.013052 DO - 10.1136/ard.2003.013052 ID - van de Putte2004 ER - TY - JOUR AU - Breedveld, F. C. AU - Weisman, M. H. AU - Kavanaugh, A. F. AU - Cohen, S. B. AU - Pavelka, K. AU - van Vollenhoven, R. AU - Sharp, J. AU - Perez, J. L. AU - Spencer-Green, G. T. PY - 2006 DA - 2006// TI - The PREMIER study: A multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment JO - Arthritis Rheum VL - 54 UR - https://doi.org/10.1002/art.21519 DO - 10.1002/art.21519 ID - Breedveld2006 ER - TY - JOUR AU - Weinblatt, M. E. AU - Keystone, E. C. AU - Furst, D. E. AU - Kavanaugh, A. F. AU - Chartash, E. K. AU - Segurado, O. G. PY - 2006 DA - 2006// TI - Long term efficacy and safety of adalimumab plus methotrexate in patients with rheumatoid arthritis: ARMADA 4 year extended study JO - Ann Rheum Dis VL - 65 UR - https://doi.org/10.1136/ard.2005.044404 DO - 10.1136/ard.2005.044404 ID - Weinblatt2006 ER - TY - JOUR AU - van der Heijde, D. AU - Breedveld, F. C. AU - Kavanaugh, A. AU - Keystone, E. C. AU - Landewe, R. AU - Patra, K. AU - Pangan, A. L. PY - 2010 DA - 2010// TI - Disease activity, physical function, and radiographic progression after longterm therapy with adalimumab plus methotrexate: 5-year results of PREMIER JO - J Rheumatol VL - 37 UR - https://doi.org/10.3899/jrheum.100208 DO - 10.3899/jrheum.100208 ID - van der Heijde2010 ER - TY - CHAP AU - Keystone, E. C. AU - Kavanaugh, A. AU - Weinblatt, M. E. AU - Patra, K. AU - Pangan, A. L. PY - 2011 DA - 2011// TI - Clinical Consequences of Delayed Addition of Adalimumab to Methotrexate Therapy Over 5 Years in Patients with Rheumatoid Arthritis BT - J Rheumatol ID - Keystone2011 ER - TY - JOUR AU - Arnett, F. C. AU - Edworthy, S. M. AU - Bloch, D. A. AU - McShane, D. J. AU - Fries, J. F. AU - Cooper, N. S. AU - Healey, L. A. AU - Kaplan, S. R. AU - Liang, M. H. AU - Luthra, H. S. PY - 1988 DA - 1988// TI - The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis JO - Arthritis Rheum VL - 31 UR - https://doi.org/10.1002/art.1780310302 DO - 10.1002/art.1780310302 ID - Arnett1988 ER - TY - JOUR AU - Prevoo, M. L. AU - van 't Hof, M. A. AU - Kuper, H. H. AU - van Leeuwen, M. A. AU - van de Putte, L. B. AU - van Riel, P. L. PY - 1995 DA - 1995// TI - Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis JO - Arthritis Rheum VL - 38 UR - https://doi.org/10.1002/art.1780380107 DO - 10.1002/art.1780380107 ID - Prevoo1995 ER - TY - JOUR AU - Fries, J. F. AU - Spitz, P. W. AU - Young, D. Y. PY - 1982 DA - 1982// TI - The dimensions of health outcomes: the health assessment questionnaire, disability and pain scales JO - J Rheumatol VL - 9 ID - Fries1982 ER - TY - JOUR AU - Fransen, J. AU - van Riel, P. L. PY - 2005 DA - 2005// TI - The Disease Activity Score and the EULAR response criteria JO - Clin Exp Rheumatol VL - 23 ID - Fransen2005 ER - TY - JOUR AU - Black, N. PY - 1996 DA - 1996// TI - Why we need observational studies to evaluate the effectiveness of health care JO - Bmj VL - 312 UR - https://doi.org/10.1136/bmj.312.7040.1215 DO - 10.1136/bmj.312.7040.1215 ID - Black1996 ER - TY - JOUR AU - Curtis, J. R. AU - Jain, A. AU - Askling, J. AU - Bridges, S. L. AU - Carmona, L. AU - Dixon, W. AU - Finckh, A. AU - Hyrich, K. AU - Greenberg, J. D. AU - Kremer, J. PY - 2010 DA - 2010// TI - A comparison of patient characteristics and outcomes in selected European and U.S. rheumatoid arthritis registries JO - Semin Arthritis Rheum VL - 40 UR - https://doi.org/10.1016/j.semarthrit.2010.03.003 DO - 10.1016/j.semarthrit.2010.03.003 ID - Curtis2010 ER - TY - JOUR AU - Bombardieri, S. AU - Ruiz, A. A. AU - Fardellone, P. AU - Geusens, P. AU - McKenna, F. AU - Unnebrink, K. AU - Oezer, U. AU - Kary, S. AU - Kupper, H. AU - Burmester, G. R. PY - 2007 DA - 2007// TI - Effectiveness of adalimumab for rheumatoid arthritis in patients with a history of TNF-antagonist therapy in clinical practice JO - Rheumatology (Oxford) VL - 46 UR - https://doi.org/10.1093/rheumatology/kem091 DO - 10.1093/rheumatology/kem091 ID - Bombardieri2007 ER - TY - JOUR AU - Burmester, G. R. AU - Mease, P. AU - Dijkmans, B. A. AU - Gordon, K. AU - Lovell, D. AU - Panaccione, R. AU - Perez, J. AU - Pangan, A. L. PY - 2009 DA - 2009// TI - Adalimumab safety and mortality rates from global clinical trials of six immune-mediated inflammatory diseases JO - Ann Rheum Dis VL - 68 UR - https://doi.org/10.1136/ard.2008.102103 DO - 10.1136/ard.2008.102103 ID - Burmester2009 ER - TY - JOUR AU - Schiff, M. H. AU - Burmester, G. R. AU - Kent, J. D. AU - Pangan, A. L. AU - Kupper, H. AU - Fitzpatrick, S. B. AU - Donovan, C. PY - 2006 DA - 2006// TI - Safety analyses of adalimumab (HUMIRA) in global clinical trials and US postmarketing surveillance of patients with rheumatoid arthritis JO - Ann Rheum Dis VL - 65 UR - https://doi.org/10.1136/ard.2005.043166 DO - 10.1136/ard.2005.043166 ID - Schiff2006 ER - TY - STD TI - The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2474/12/261/prepub UR - http://www.biomedcentral.com/1471-2474/12/261/prepub ID - ref27 ER -